TRxADE HEALTH INC
For the period ended Dec 31, 2023. Filed Apr 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| TRxADE HEALTH, INC. | ||
| Date: April 22, 2024 | /s/ Suren Ajjarapu | |
|---|---|---|
| By: | Suren Ajjarapu, Chief Executive Officer (Principal Executive Officer) | |
| Date: April 22, 2024 | /s/ Prashant Patel | |
| By: | Prashant Patel (Principal Financial and Accounting Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Suren Ajjarapu | Chairman of the Board, Chief Executive Officer and Secretary | April 22, 2024 |
| Suren Ajjarapu | (Principal Executive Officer) | |
| /s/ Prashant Patel | Director, President, Principal Accounting Officer and Chief Operating Officer | April 22, 2024 |
| Prashant Patel | ||
| /s/ Donald G. Fell | Director | April 22, 2024 |
| Donald G. Fell | ||
| /s/ Jeff Newell | Director | April 22, 2024 |
| Jeff Newell | ||
| /s/ Michael L. Peterson | Director | April 22, 2024 |
| Michael L. Peterson | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.